Acrivastine/Pseudoephedrine Hydrochloride

阿伐斯汀/盐酸伪麻黄碱

Report date: 2022/03/22 11:18:42

Base Information

Drug NameAcrivastine/Pseudoephedrine Hydrochloride
Drug Alias NameSemprex-D
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha adrenergic receptor agonistsHistamine H1 receptor antagonists
TargetsAlpha adrenergic receptorHistamine H1 receptor
Therapy Area/IndicationsRhinitis, Allergic
Global Approved IndicationsRhinitis, Allergic
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1994/03/25
Country/TerritoryUnited States
CombinationsYes Pseudoephedrine HydrochlorideAcrivastine
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesCelltechUcb Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEndo Operations Ltd
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic

Other Information

ATC CodeR01BA52
Related LinksWikipedia